Investment Summary

The BroadOak Fund Invests In Microsize

On July 1, 2022, growth capital firm The BroadOak Fund invested in life science company Microsize

Investment Highlights
  • This is The BroadOak Fund’s 17th transaction in the Life Science sector.
  • This is The BroadOak Fund’s 20th transaction in the United States.
  • This is The BroadOak Fund’s 2nd transaction in Pennsylvania.

Investment Summary
Date 2022-07-01
Target Microsize
Sector Life Science
Investor(s) The BroadOak Fund
Deal Type Growth Capital

Target

Microsize

Quakertown, Pennsylvania, United States
Microsize specializes in particle size reduction, powder classification, and analytical services, catering to a diverse clientele, including small biotechs, big pharma, CDMOs (API, Dosage Form, Integrated), and functional excipient companies. Microsize expertise in milling and micronization processes enables to develop and manufacture products with unique physical property challenges. Microsize was founded in 1994 and is based in Quakertown, Pennsylvania.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

The BroadOak Fund

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Size Small
Type Sector Focused
DESCRIPTION

The BroadOak Fund is the investment affiliate of life science focused investment bank BroadOak Capital Partners. The BroadOak Fund provides growth capital to life sciences tools and service providers that have achieved a level of commercial success. The BroadOak Fund is based in Bethesda, Maryland.

DEAL STATS #
Overall 21 of 25
Sector (Life Science) 17 of 20
Type (Growth Capital) 11 of 14
State (Pennsylvania) 2 of 2
Country (United States) 20 of 23
Year (2022) 5 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-07 LabVoice

Carrboro, North Carolina, United States

LabVoice is a developer of a hands-free voice assistant to simplify your laboratory processes by creating a common human-lab interaction, allowing scientists to focus on the science. LabVoice is based in Carrboro, North Carolina.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-01 Flagship Biosciences

Broomfield, Colorado, United States

Flagship Biosciences is a technology-driven tissue analysis services company delivering accurate and informative data available. Flagship Biosciences' services and technology dramatically improve the data and interpretation from traditional pathology methods, eliminating variability associated with typical tissue assessments, and bringing new insights to tissue analysis results. It provides expert scientific consultation for every client. The company's team interprets results, contextualizes tissue biology, and identifies the best course for success. Flagship Biosciences was formed in 2009 and is based in Broomfield, Colorado.

Buy -
Mergr

Product

Company

Legal